Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Ward

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
Lancet (London, England)|December 11, 1976
Inosine in experimental acute renal failureA R Fernando, D M Armstrong, J R Griffiths, et al.
Nature Communications|September 17, 2017
Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8<sup>+</sup> T cellsM Fehlings, Y Simoni, H L Penny, et al.
Nature Communications|July 28, 2018
Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8<sup>+</sup> T cellsM Fehlings, Y Simoni, H L Penny, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
Lancet (London, England)|December 11, 1976
Inosine in experimental acute renal failureA R Fernando, D M Armstrong, J R Griffiths, et al.
Nature Communications|September 17, 2017
Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8<sup>+</sup> T cellsM Fehlings, Y Simoni, H L Penny, et al.
Nature Communications|July 28, 2018
Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8<sup>+</sup> T cellsM Fehlings, Y Simoni, H L Penny, et al.
Pageof 14